Shortage reports
Actual shortage:
65 (10%)
Anticipated shortage:
15 (2%)
Avoided shortage:
16 (2%)
Resolved:
570 (86%)
666
Discontinuation Reports
To be discontinued:
7 (10%)
Discontinued:
54 (75%)
Reversed:
11 (15%)
72
52 (7%)
17 (20%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MOXIFLOXACIN | 400MG | TABLET | Resolved | 2025-02-18 | 2025-08-30 | 250601 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2020-07-08 | 2020-12-11 | 119728 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217798 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211089 |
| MYCOPHENOLATE MOFETIL | 250MG | CAPSULE | Resolved | 2020-01-14 | 2020-11-19 | 103285 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2020-01-20 | 2020-02-27 | 103701 |
| NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-25 | 2018-12-11 | 56416 |
| NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2018-05-16 | 2018-08-16 | 49537 |
| OLANZAPINE | 10MG | TABLET | Resolved | 2025-09-03 | 2025-11-27 | 266490 |
| OLANZAPINE | 7.5MG | TABLET | Resolved | 2025-08-11 | 2025-08-30 | 265010 |
| OLANZAPINE | 7.5MG | TABLET | Resolved | 2025-02-10 | 2025-05-06 | 249876 |
| OLANZAPINE | 15MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198789 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-06-06 | 2018-09-28 | 12095 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-11-25 | 2025-03-05 | 243713 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-11-27 | 2018-12-11 | 30725 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-09-28 | 21989 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Avoided shortage | 2024-07-03 | 2024-07-15 | 232029 |
| OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-09-13 | 2018-11-16 | 21992 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| SOLIFENACIN | 10MG | TABLET | Reversed | 2024-07-24 | 2025-01-13 | 233602 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |